Dexcom stock has been steadily gaining value since the crash, rising to $85 per share at the time of writing, although this represents a discount of 35% to its price immediately prior to the Q2 ...
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A better-than-expected third-quarter 2024 performance and a series of favorable coverage ...
Bernstein raised the firm’s price target on DexCom (DXCM) to $89 from $86 and keeps an Outperform rating on the shares as part of a broader research note indicating that the firm is positive on ...